US Stock MarketDetailed Quotes
AFJK Aimei Health Technology
- 10.610
- +0.010+0.09%
Close Nov 29 13:00 ET
95.77MMarket Cap0.00P/E (TTM)
10.610High10.610Low221Volume10.610Open10.600Pre Close2.35KTurnover0.00%Turnover Ratio0.00P/E (Static)9.03MShares10.68552wk High1.33P/B71.74MFloat Cap10.15052wk Low--Dividend TTM6.76MShs Float10.685Historical High--Div YieldTTM0.00%Amplitude10.150Historical Low10.610Avg Price1Lot Size
Aimei Health Technology Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||
| Cash flow from continuing operating activities | -53.95K | -256.24K | -166.97K |
| Net income from continuing operations | --743.51K | --609.09K | --755.5K |
| Other non cash items | ---943.53K | ---918.21K | ---909.13K |
| Change In working capital | --146.07K | --52.87K | ---13.34K |
| -Change in receivables | ---- | ---- | ---302 |
| -Change in prepaid assets | --26.5K | --19.83K | ---66.67K |
| -Change in payables and accrued expense | --119.57K | --32.74K | --53.63K |
| Cash from discontinued investing activities | |||
| Operating cash flow | ---53.95K | ---256.24K | ---166.97K |
| Investing cash flow | |||
| Cash flow from continuing investing activities | |||
| Cash from discontinued investing activities | |||
| Financing cash flow | |||
| Cash flow from continuing financing activities | |||
| Cash from discontinued financing activities | |||
| Net cash flow | |||
| Beginning cash position | --157.51K | --413.75K | --580.72K |
| Current changes in cash | ---53.95K | ---256.24K | ---166.97K |
| End cash Position | --103.56K | --157.51K | --413.75K |
| Free cash flow | ---53.95K | ---256.24K | ---166.97K |
| Currency Unit | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data